Antibacterial activity of recombinant endolysin LysNOVA-I against growing/non-growing and planktonic/biofilm cultures of Staphylococcus aureus strains
Our findings highlight the clinical potential of rLysNOVA-I as a therapeutic or complementary alternative to antibiotics against multidrug-resistant S. aureus infections in human and veterinary medicine.
Authors
- Andrea Balan (ORCID: https://orcid.org/0000-0001-6199-3198)
- Benedito Matheus dos Santos (ORCID: https://orcid.org/0000-0002-2196-260X)
- Lúcio H. Freitas-Júnior (ORCID: https://orcid.org/0000-0002-8904-7897)
- Nilton Lincopán (ORCID: https://orcid.org/0000-0003-0161-5800)
- Alejandra Victoria Capozzo
- Melina Martínez (ORCID: https://orcid.org/0000-0002-4007-8721)
- Claudio Paolazzi
- Johana Becerra
- Danilo Ribeiro de Oliveira (ORCID: https://orcid.org/0000-0001-5697-6510)
- Luís Carlos de Souza Ferreira (ORCID: https://orcid.org/0000-0002-4883-1693)
- Eduardo G. Martins (ORCID: https://orcid.org/0000-0003-3500-9331)
- Nicole Gonçalves Picinin
- Carla Rivero
- Leticia V. Bentancor
- Rita de Cássia Café Ferreira (ORCID: https://orcid.org/0000-0002-6872-7244)
Institutions
- Consejo Nacional de Investigaciones Científicas y Técnicas (AR)
- Universidade de São Paulo (BR)
- Universidad Nacional de La Pampa (AR)
- Universidad Abierta Interamericana (AR)
- Centro Científico Tecnológico - San Juan (AR)
- Institute of Biomedical Science (GB)
- National Food Safety and Quality Service (AR)
Publication Details
- Journal
- Journal of Global Antimicrobial Resistance
- Published
- 2025-11-22
- DOI
- https://doi.org/10.1016/j.jgar.2025.11.014
- Primary Topic
- Antimicrobial Peptides and Activities
- Type
- article
- Field-Weighted Citation Impact
- 0.00